Pacira Pharmaceuticals Inc (NASDAQ:PCRX)

34.50
Delayed Data
As of Apr 25
 -0.80 / -2.27%
Today’s Change
26.95
Today|||52-Week Range
52.48
-24.42%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-13.7M1.9M-37.9M-42.6M
 
 
 
 
 
Depreciation10.0M11.5M12.9M13.8M
 
 
 
 
 
Total Other Cash Flow29.6M38.0M36.2M49.1M
 
 
 
 
 
Funds From Operations25.9M51.3M11.2M20.4M
 
 
 
 
 
Funds From/For Other Operating Expenses-514.0K23.6M-22.3M2.6M
 
 
 
 
 
Net Cash Flow - Operating Activities26.4M27.8M33.5M17.8M
 
 
 
 
 
 
InvestingIncrease In Investments-164.3M-189.1M-192.8M-517.8M
 
 
 
 
 
Decrease In Investments80.3M217.2M171.6M321.7M
 
 
 
 
 
Capital Expenditures-21.9M-41.3M-24.7M-19.3M
 
 
 
 
 
Other Investing - Uses-13.4M-7.1M-15.9M-8.5M
 
 
 
 
 
Net Cash Flow Investing-119.3M-20.2M-61.8M-223.8M
 
 
 
 
 
 
FinancingShort Term Borrowings-970.0K-276.0K0.00-118.2M
 
 
 
 
Long Term Borrowings0.000.00--333.7M
 
 
Long Term Debt Reduction0.00-1.5M-4.0K--
 
 
 
Net Proceeds Stock Sale118.9M12.2M7.3M8.6M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing117.9M10.4M7.3M224.2M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.00--------
 
Net Change In Cash25.0M18.0M-21.0M18.2M